Company profile: PharmaTher
1.1 - Company Overview
Company description
- Provider of ketamine-based medicines, developing KETARX (ketamine HCl injection) for anesthesia and procedural sedation via FDA ANDA; a hydrogel microneedle ketamine patch for neuropsychiatric, neurodegenerative and pain disorders; and PD-001, an oral enteric-coated cepharanthine for responsive cancers and infectious diseases.
Products and services
- Ketamine Patch: PharmaTher architects a hydrogel-forming microneedle patch that delivers ketamine, targeting treatment for neuropsychiatric, neurodegenerative, and pain disorders
- KETARX™: PharmaTher engineers Ketamine Hydrochloride Injection USP for anesthesia and procedural sedation, aiming for FDA approval via an Abbreviated New Drug Application
- PD-001: Sairiyo Therapeutics, partly owned by PharmaTher, produces a patented enteric-coated, orally bioavailable cepharanthine formulation for treating responsive cancers and infectious diseases
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PharmaTher
PHT
HQ: United States
Website
- Description: Provider of Web-based clinical trial direct data capture and management technologies, including market-leading electronic patient reported outcome (ePRO) solutions used globally in clinical trials. Offers LogPad and StudyPad systems to improve data quality and the StudyWorks online portal providing study sponsors, monitors and sites with real-time access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PHT company profile →
Pharma Intelligence
HQ: United Kingdom
Website
- Description: Provider of analysis, insight, and consultancy services for pharmaceutical, MedTech, and clinical research organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharma Intelligence company profile →
OmicEra
HQ: Germany
Website
- Description: Provider of proteomics and artificial intelligence (AI) capabilities for medical diagnostics, leveraging high-end mass spectrometry-based proteomics to improve human health, with transparency, reproducible results, and open-source software development at its core.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OmicEra company profile →
Lean Library
HQ: The Netherlands
Website
- Description: Provider of library technology including Lean Library, a browser extension integrating library resources and Open Access alternatives into online workflows; Talis Aspire for structured reading lists and analytics; Talis Elevate for collaborative annotations and engagement insights; Talis CourseFlow for course resource lists; Sciwheel for reference management; and consulting for data migration, system integration, and process optimization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lean Library company profile →
Sware
HQ: United States
Website
- Description: Provider of a validation automation platform and managed services for life sciences. Res_Q automates and unifies GxP validation to reduce validation time and ensure audit readiness. Managed Services Programs support implementation and management of Res_Q, including training and ongoing compliance assistance. Industry Accelerators via Sware's Marketplace offer over 30 integrated applications to expedite implementation and automate compliance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sware company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PharmaTher
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PharmaTher
2.2 - Growth funds investing in similar companies to PharmaTher
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PharmaTher
4.2 - Public trading comparable groups for PharmaTher
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →